Media-OutReach Newswire The global leader in rabies vaccines, the serum-free iterative rabies vaccine of AIM Vaccine has submitted a pre-application for marketing registration
Media-OutReach Newswire Immuno Cure Biotech Presents Promising Results on Phase I Clinical Trial of a Therapeutic HIV DNA Vaccine
Media-OutReach Newswire AIM Vaccine’s heavyweight single-product mRNA RSV Vaccine obtained the clinical trial approval
Media-OutReach Newswire Vinpearl's Multi-Experience Resorts: A "Back to Nature" Experience That's Anything But Boring
Media-OutReach Newswire HKU AIDS Institute & Immuno Cure’s Collaborative Therapeutic HIV Vaccine Research Project secured HK$66.7m TRS funding from Research Grant Council
Media-OutReach Newswire Berlin Cures' BC 007 Targeting Long COVID Achieves Solid Progress with Over 50% Patient Recruitment in Phase II Trial
Media-OutReach Newswire Berlin Cures' BC 007 Targets Long COVID: Solid Phase II Trial Progress with Over 50% Patient Recruitment
Media-OutReach Newswire Watsons Singapore Launches Tru Niagen® Immune, a Groundbreaking Formula for Age Transformation and Immunity Boost